newsfilter
← Latest News
FDA Approved Drugs·

Approval of CONEXXENCE, BLA #761398

Approval Date: 11/03/2026 Drug Name: CONEXXENCE, BLA #761398 Submission: SUPPL-3 Active Ingredients: DENOSUMAB-BNHT Company: FRESENIUS KABI USA LLC Submission Status: Approval Application Number: 761398

Company
FRESENIUS KABI USA LLC
Keywords
DENOSUMAB-BNHT